DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21

PRECISION BIOSCIENCES INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$6.19+0.42 (+7.28%)

Close on Oct 19, 2026

Dividends

No dividend per share appears in Precision Biosciences's annual filings since fiscal 2017.

Parsed from the XBRL in Precision Biosciences's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-30 reverse split on Feb 14, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is DTIL.

Revenue growth3473.0% · median -45.8%

Operating margin-80.8% · median -357.5%

Net margin-117.0% · median -356.9%

Advertisement
300 × 250